Maze Therapeutics (MAZE) Change in Cash (2024 - 2026)
Maze Therapeutics (MAZE) posted Change in Cash of $9.5 million for Q1 2026, up 107.46% sequentially from -$127.5 million in Q4 2025, and down 90.24% YoY from $97.6 million in Q1 2025.
Maze Therapeutics (MAZE) Change in Cash (2024 - 2026) Analysis & Trends
Maze Therapeutics has reported Change in Cash for 3 years, with the latest figure at $9.5 million in Q1 2026.
- Quarterly Change in Cash fell 90.24% year-over-year to $9.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$95.6 million (down 136.17% YoY) and the FY2025 annual result came in at -$7.6 million, down 104.51% from the prior year.
- Change in Cash climbed to $9.5 million in Q1 2026 per MAZE's latest filing, from -$127.5 million in the prior quarter.
- Over five years, Change in Cash peaked at $145.0 million in Q2 2024 and troughed at -$127.5 million in Q4 2025.
- A 3-year average of $18.8 million and a median of $9.5 million in 2026 frame the typical range for Change in Cash.
- The widest YoY moves for Change in Cash: up 11178.96% in 2025, down 370.16% in 2025.
- Over 3 years, Change in Cash stood at $47.2 million in 2024, then plunged by 370.16% to -$127.5 million in 2025, then jumped by 107.46% to $9.5 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $9.5 million, -$127.5 million, and $52.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Maze Therapeutics | 1.51 Bn | 1.51 Bn | - | 3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.88 Mn |
| Mar 31, 2026 | 9.52 Mn |
| Dec 31, 2025 | -127.53 Mn |
| Sep 30, 2025 | 52.23 Mn |
| Jun 30, 2025 | -29.83 Mn |
| Mar 31, 2025 | 97.56 Mn |
| Dec 31, 2024 | 47.21 Mn |
| Sep 30, 2024 | -25.46 Mn |
| Jun 30, 2024 | 145.04 Mn |
| Mar 31, 2024 | 865,000.00 |